Compound Detail
CHEMBL169
URSOLIC ACID 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12
Basic Information
| ChEMBL ID | CHEMBL169 |
| Name | URSOLIC ACID |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | WCGUUGGRBIKTOS-GPOJBZKASA-N |
94
Targets
291
Activities
4
Assay Types
10
PK Parameters
20
Publications
7
Known Names
3
Indications
Molecular Properties
456.7
MW (Da)
7.09
ALogP
2
HBA
2
HBD
57.5
PSA (Ų)
0.41
QED
1
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Metabolic Syndrome Cholangitis, Sclerosing Prostatic Neoplasms, Castration-Resistant
Activity Summary
IC50 242 meas. best 9.12
EC50 39 meas. best 8.0
Ki 9 meas. best 6.05
Kd 1 meas. best 4.33
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nuclear receptor ROR-gamma CHEMBL1741186 | IC50 | 9.12 | 6.636 | 0.8 | 5 |
| Unchecked CHEMBL612545 | IC50 | 8.6 | 5.0828 | 2.5 | 25 |
| Sentrin-specific protease 1 CHEMBL1909484 | IC50 | 8.19 | 6.4533 | 6.4 | 3 |
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 8.0 | 8.0 | 10.0 | 1 |
| Transcription factor p65 CHEMBL5533 | IC50 | 7.51 | 7.51 | 31.0 | 1 |
| Liver carboxylesterase 1 CHEMBL2265 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Streptococcus CHEMBL612313 | EC50 | 6.06 | 6.06 | 880.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.05 | 6.05 | 900.0 | 1 |
| Streptococcus sp. 'group A' CHEMBL612389 | EC50 | 6.02 | 6.02 | 949.0 | 1 |
| Toxoplasma gondii CHEMBL612888 | IC50 | 6.0 | 5.615 | 1000.0 | 2 |
| G-protein coupled bile acid receptor 1 CHEMBL5409 | EC50 | 5.96 | 5.9 | 1100.0 | 2 |
| Streptokinase A CHEMBL1293228 | EC50 | 5.75 | 5.75 | 1790.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 5.75 | 4.8217 | 1800.0 | 6 |
| 11-beta-hydroxysteroid dehydrogenase 1 CHEMBL4235 | IC50 | 5.72 | 5.72 | 1900.0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 CHEMBL335 | Ki | 5.7 | 5.4533 | 2000.0 | 3 |
| Aldo-keto reductase family 1 member B10 CHEMBL5983 | Ki | 5.7 | 5.516 | 2000.0 | 5 |
| Trypanosoma brucei brucei CHEMBL612851 | IC50 | 5.66 | 5.66 | 2200.0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 CHEMBL335 | IC50 | 5.64 | 5.29 | 2300.0 | 43 |
| Acidic phospholipase A2 EC-I CHEMBL4195 | IC50 | 5.64 | 5.64 | 2300.0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 2 CHEMBL3807 | IC50 | 5.62 | 5.4233 | 2400.0 | 3 |
| Basic phospholipase A2 PLA-A CHEMBL5022 | IC50 | 5.6 | 5.6 | 2500.0 | 1 |
| Basic phospholipase A2 1 CHEMBL3967 | IC50 | 5.54 | 5.54 | 2900.0 | 1 |
| B16 CHEMBL381 | IC50 | 5.51 | 5.51 | 3100.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 5.46 | 4.81 | 3500.0 | 4 |
| Receptor-type tyrosine-protein phosphatase F CHEMBL3521 | IC50 | 5.42 | 5.42 | 3800.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 5.4 | 5.4 | 4000.0 | 2 |
| Aldo-keto reductase family 1 member B10 CHEMBL5983 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| Trypanosoma brucei CHEMBL612849 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| NCI-N87 CHEMBL614197 | IC50 | 5.38 | 5.38 | 4200.0 | 1 |
| H9 CHEMBL614806 | EC50 | 5.36 | 5.36 | 4400.0 | 1 |
| DNA polymerase beta CHEMBL4343 | IC50 | 5.32 | 5.195 | 4800.0 | 2 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.23 | 4.7467 | 5900.0 | 3 |
| MCF7 CHEMBL387 | IC50 | 5.18 | 4.635 | 6600.0 | 8 |
| Ubiquitin carboxyl-terminal hydrolase 7 CHEMBL2157850 | IC50 | 5.16 | 5.16 | 7000.0 | 2 |
| Low molecular weight phosphotyrosine protein phosphatase CHEMBL4903 | IC50 | 5.14 | 5.05 | 7200.0 | 2 |
| Protease CHEMBL2366517 | IC50 | 5.1 | 5.1 | 8000.0 | 1 |
| CAPAN-1 CHEMBL614536 | IC50 | 5.07 | 5.07 | 8600.0 | 1 |
| L02 CHEMBL4296457 | IC50 | 5.05 | 4.64 | 8850.0 | 2 |
| Glycogen phosphorylase, muscle form CHEMBL4696 | IC50 | 5.05 | 4.9925 | 8912.5 | 4 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 5.04 | 4.647 | 9100.0 | 10 |
| THP-1 CHEMBL614245 | IC50 | 5.04 | 5.04 | 9100.0 | 1 |
| HL-60 CHEMBL383 | IC50 | 5.02 | 4.85 | 9500.0 | 2 |
| Z-138 CHEMBL4483276 | IC50 | 5.01 | 5.01 | 9800.0 | 1 |
| K562 CHEMBL385 | IC50 | 4.99 | 4.69 | 10200.0 | 2 |
| MIA PaCa-2 CHEMBL614725 | IC50 | 4.98 | 4.98 | 10400.0 | 1 |
| HT-29 CHEMBL384 | EC50 | 4.97 | 4.97 | 10600.0 | 5 |
| HepG2 CHEMBL395 | IC50 | 4.96 | 4.4582 | 10840.0 | 11 |
| Solute carrier organic anion transporter family member 1B3 CHEMBL1743121 | IC50 | 4.94 | 4.94 | 11481.5 | 1 |
| A549 CHEMBL392 | IC50 | 4.94 | 4.5 | 11400.0 | 11 |
| Lu1 CHEMBL613290 | IC50 | 4.94 | 4.94 | 11500.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 114.3 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 0.6 | ng.hr.mL-1 | Rattus norvegicus |
| Cmax | 0.378 | ug.mL-1 | Rattus norvegicus |
| Cmax | 0.0019 | ug.mL-1 | Rattus norvegicus |
| F | 0.01 | % | Rattus norvegicus |
| Ka | 1.3 | 10^4/M | Homo sapiens |
| T1/2 | 1.55 | hr | Rattus norvegicus |
| T1/2 | 0.3 | hr | Rattus norvegicus |
| Tmax | 0.08 | hr | Rattus norvegicus |
| Tmax | 0.25 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine